SCHEMBL4483014

SCHEMBL4483014

COc1cc(C=CC=C(C#N)C#N)cc(OC)c1O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 11/20 0.58
MAPT P10636 4/20 0.58
KMT2A Q03164 4/20 0.58
CYP3A4 P08684 3/20 0.58
MEN1 O00255 3/20 0.58
CYP1A2 P05177 2/20 0.58
CYP2C9 P11712 2/20 0.58
KDM4E B2RXH2 2/20 0.58
LMNA P02545 2/20 0.58
HPGD P15428 2/20 0.58
BLM P54132 2/20 0.58
SMN1; SMN2 Q16637 2/20 0.58
RGS12 O14924 1/20 0.58
GMNN O75496 1/20 0.58
USP2 O75604 1/20 0.58
ALDH1A1 P00352 1/20 0.58
ALOX15 P16050 1/20 0.58
NFKB1 P19838 1/20 0.58
GNAI1 P63096 1/20 0.58
PMP22 Q01453 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4483009 1.00 EGFR (0.58) EGFRMAPTKMT2ACYP3A4MEN1
SCHEMBL14381045 0.86 ABL1 (0.50) EGFRMAPTKMT2ACYP3A4MEN1
SCHEMBL13678150 0.81 CYP1A2 (0.51) EGFRMAPTKMT2ACYP3A4MEN1
SCHEMBL4481016 0.81 PKM (0.54) EGFRMAPTKMT2ACYP3A4MEN1
SCHEMBL4481022 0.81 PKM (0.54) EGFRMAPTKMT2ACYP3A4MEN1
SCHEMBL8817683 0.80 ABL1 (0.68) MAPTKMT2ACYP3A4MEN1CYP1A2
SCHEMBL6029599 0.80 EGFR (0.49) EGFRMAPTKMT2ACYP3A4MEN1
SCHEMBL6028927 0.80 MCL1 (0.56) EGFRKMT2ACYP3A4CYP1A2CYP2C9
SCHEMBL6028926 0.80 MCL1 (0.56) EGFRKMT2ACYP3A4CYP1A2CYP2C9
SCHEMBL4488546 0.80 APP (0.52) EGFRMAPTKMT2ACYP3A4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7598419-B2 Compounds for modulating cell proliferation HSC RESEARCH AND DEVELOPMENT LIMITED PARTNERSHIP (CA) 2009-10-06 US disclosed
US-20070243612-A1 Novel Compounds for Modulating Cell Proliferation HSC RESEARCH AND DEVELOPMENT LIMITED PARTNERSHIP (CA) 2007-10-18 US disclosed
EP-1727822-A4 NOVEL COMPOUNDS FOR MODULATING CELL PROLIFERATION HSC RES DEV LP (CA) 2007-05-09 EP disclosed
EP-1727822-A1 NOVEL COMPOUNDS FOR MODULATING CELL PROLIFERATION HSC Research and Development Limited Partnership (CA) 2006-12-06 EP disclosed
WO-2005092904-A1 NOVEL COMPOUNDS FOR MODULATING CELL PROLIFERATION HSC RESEARCH AND DEVELOPMENT LIMITED PARTNERSHIP (CA) 2005-10-06 WO disclosed
US-20050014690-A1 Styryl acrylonitrile compounds and their use to promote myelopoiesis THE HOSPITAL FOR SICK CHILDREN (CA) 2005-01-20 US disclosed
EP-1453500-A1 STYRYL ACRYLONITRILE COMPOUNDS AND THEIR USE TO PROMOTE MYELOPOIESIS THE HOSPITAL FOR SICK CHILDREN (CA) 2004-09-08 EP disclosed
WO-2003030895-A1 STYRYL ACRYLONITRILE COMPOUNDS AND THEIR USE TO PROMOTE MYELOPOIESIS THE HOSPITAL FOR SICK CHILDREN (CA) 2003-04-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070243612-A1 Novel Compounds for Modulating Cell Proliferation MKI67, CCNA1, PCNA EGFR 1713/4885MAPT 4784/4885KMT2A 3146/4885
US-20050014690-A1 Styryl acrylonitrile compounds and their use to promote myelopoiesis MCL1, MYD88, MYADM EGFR 2620/4885MAPT 3993/4885KMT2A 1728/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.